MAIA Biotechnology, Inc. Board of Directors

MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Dr. Vlad Vitoc M.B.A., M.D.

Dr. Vlad Vitoc M.B.A., M.D.

Co-Founder, President, CEO & Chairman of the Board of Directors

Dr. Sergei M. Gryaznov Ph.D.

Dr. Sergei M. Gryaznov Ph.D.

Chief Scientific Officer

Linda Moreira

Linda Moreira

Company Secretary

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.